Evidence map›Paper›PMID 35622311›Full record

ReviewCurrent pain and headache reports2022

Meralgia Paresthetica.

Jane Nithya Tolson Solomons, Afrin Sagir, Cyrus Yazdi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pain and headache reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Meralgia paraesthetica.BJA education · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Meralgia Paresthetica: Relevance, Diagnosis, and Treatment.Deutsches Arzteblatt international · 2023
    Review
  17. Chiropractic management of bilateral meralgia paresthetica: a case report.The Journal of the Canadian Chiropractic Association · 2023
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jane Nithya Tolson SolomonsBeth Israel Deaconess Medical Center, Brookline, MA, USA.
Afrin SagirBeth Israel Deaconess Medical Center, Brookline, MA, USA.
Cyrus YazdiBeth Israel Deaconess Medical Center, Brookline, MA, USA. cyazdi@bidmc.harvard.edu.
Beth Israel Deaconess Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review article summaries the epidemiology, etiology, clinical presentations, and latest treatment modalities of meralgia paresthetica, including the latest data about peripheral and spinal cord stimulation therapy. Meralgia paresthetica (MP) causes burning, stinging, or numbness in the anterolateral part of the thigh, usually due to compression of the lateral femoral cutaneous nerve (LFCN). RECENT

findingsThere are emerging data regarding the benefit of interventional pain procedures, including steroid injection and radiofrequency ablation, and other interventions including spinal cord and peripheral nerve stimulation reserved for refractory cases. The strength of evidence for treatment choices in meralgia paraesthetica is weak. Some observational studies are comparing local injection of corticosteroid versus surgical interventions. However, more extensive studies are needed regarding the long-term benefit of peripheral and spinal cord stimulation therapy.

Indexed as

Catheter AblationFemoral NeuropathyNerve Compression SyndromesHumansThighLateral femoral cutaneous nerveMeralgia parestheticaPeripheral nerve stimulatorSpinal cord stimulator for meralgiaSurgical treatment for meralgia

Identifiers

PMID35622311
OpenAlexW4281770959

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.